Horizon Pharma PLC is a specialty pharmaceutical company. The Company\'s product portfolio consists of ACTIMMUNE, DUEXIS, PENNSAID 2% and RAYOS/LODOTRA, which addresses the unmet therapeutic needs in arthritis, pain, inflammatory and/or orphan diseases.
| Website: | www.horizonpharma.com |
| Main Phone: | +353 17722100 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House, 1st Floor |
| City / Town: | Dublin 4 |
| Country: | IRL |
| Postal Code: | 60015 |
| Exchange: | NGS |
| Employees: | 750 |
| NAICS: | Pharmaceutical P |
| Last Price 13.31 | Change $ 0.17 | Change % 1.29 | Tick N/A |
| Bid 12.93 | Bid Size 5,000.00 | Ask 13.31 | Ask Size 200.00 |
| Open 12.90 | High 13.43 | Low 12.64 | Prev Close 13.14 |
| Last Trade | Volume 4.3 mi | 52 Wk Hi 23.08 | 52 Wk Low 9.45 |
| Market Cap 2.2 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 163,354,268.00 | EPS (TTM) -2.70 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 7 | 67 |
| Number of Buys | 3 | 37 |
| Number of Sells | 4 | 30 |
| Net Activity | 5408 | 388933 |
| Last 10 Buys | Shares |
|---|---|
| H. Thomas Watkins | 1,000 |
| H. Thomas Watkins | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeff W. Himawan | 1,000 |
| Jean-Francois Formela | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Jeffrey W. Sherman | 1,000 |
| Virinder Nohria | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeff W. Himawan | 1,000 |
| Jeff W. Himawan | 1,000 |
| Jeff W. Himawan | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 45 | 45 | 45 | 45 |
| Low Target Price Estimate | 24 | 24 | 24 | 24 |
| Mean Target Price Estimate | 32.29 | 32.29 | 32.29 | 32.29 |
| Standard Deviation | 8.46 | 8.46 | 8.46 | 8.46 |
| Date of Most Recent Estimate | 08/09/16 | 08/08/16 | 08/01/16 | 08/16/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-08 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 321 | 2016-08-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 23 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-02 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-02 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-01 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-27 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-20 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 |
| Mean Rec. | 1.29 | 1.29 | 1.47 | 1.47 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
